missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18642524

Androgen R/NR3C4 Antibody (2621E) [PerCP], Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals FAB58762C

Product Code. 18642524

  • € 631.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Androgen R/NR3C4 Monoclonal antibody specifically detects Androgen R/NR3C4 in Human samples. It is validated for Western Blot, Immunohistochemistry, Flow Cytometry (Intracellular Staining), Immunocytochemistry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Androgen R/NR3C4
Monoclonal
PerCP
PBS
Rabbit
Protein A or G purified from cell culture supernatant
RUO
Primary
Human
Purified
Western Blot, Immunohistochemistry, Flow Cytometry (Intracellular Staining), Immunocytochemistry, CyTOF
2621E
Western Blot, Immunohistochemistry, Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready
AIS, androgen receptor, DHTRTFM, Dihydrotestosterone receptorHYSP1, HUMARA, NR3C4KD, Nuclear receptor subfamily 3 group C member 4, SMAX1SBMA, spinal and bulbar muscular atrophy
Synthetic Human Androgen R/NR3C4 peptide
0.1 mL
Breast Cancer, Cancer, Cellular Markers
367
Store at 4°C in the dark.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.